Zurueck zur Suche

Reporte zur Charge UJ405AAB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
AZ 1 NV 1 GA 1 ID 1

VAERS 1147448

SANOFI PASTEUR · HIB (ACTHIB) · Charge uj405aab

mild
Staat
AZ
Alter
0,2
Geschlecht
F
Eingang
30.03.2021
Impfdatum
17.03.2021
Beginn
18.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Irritability Pyrexia

Symptomtext

Fever of 100.5 and some fussiness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Noen
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1525184

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ405AAB

gering
Staat
NV
Alter
0,6
Geschlecht
M
Eingang
04.08.2021
Impfdatum
26.07.2021
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product preparation issue

Symptomtext

ACT-HIB was given to a patient without reconstituting with proper diluent and instead it was reconstituted with sterile water/ no adverse event; Initial information received on 26-Jul-2021 regarding an unsolicited valid non-serious case received from a physician and Other Health Care Professional. This case involves a 6 month-old male patient who received HIB (PRP/T) VACCINE [ACT-HIB] without reconstituting with proper diluent (reconstituted with sterile water) [product preparation error]. The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) and DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX) for prophylactic vaccination. On 26-Jul-2021, the patient received third dose 0.5 mL (once) of suspect HIB (PRP/T) VACCINE (lot UJ405AAB and expiry date 08-Oct-2021) via an intramuscular route at the right thigh for prophylactic vaccination. It was reported that "Physician assistant student reports that he gave ACT-HIB to a patient without reconstituting with proper diluent. States he did not see diluent packaged with ACT-HIB and instead he reconstituted with sterile water". It was a case of an actual medication error due to wrong solution used in drug reconstitution (latency was on same day). At the time of report, no adverse event was reported. Event outcome was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1391222

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ405AAB

gering
Staat
GA
Alter
0,5
Geschlecht
F
Eingang
11.06.2021
Impfdatum
26.05.2021
Beginn
26.05.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation issue

Symptomtext

Patient inadvertently received a dose of ActHIb reconstituted with an MMR diluent (sterile water)/ NO AE; Initial information regarding an unsolicited valid non-serious case was received from a other health care professional via Agency (reference number- 00626689) and transmitted to Sanofi on 03-Jun-2021. This case involves a 6-months-old female patient to whom healthcare professional (HCP) administered the dose of 0.5 mL ACT-HIB (PRP/T) VACCINE [ACT-HIB] (frequency: once, strength: standard, batch number: UJ405AAB and expiry date: 08 Oct 2021via intramuscular route at left thigh administration site) after diluting with MMR diluent (sterile water) (product preparation error) on 26 May 2021 for prophylactic vaccination. The patient's medical history, past medical treatment, vaccination, and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (INFANRIX); ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for prophylactic vaccination. It was an actual medication error case due to wrong solution used in drug reconstitution (latency: same day). Reporter requested guidance on how to proceed. At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1224949

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ405AAB

gering
Staat
ID
Alter
-
Geschlecht
M
Eingang
18.04.2021
Impfdatum
25.03.2021
Beginn
25.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation issue

Symptomtext

ACTHIB was given with sterile water instead of saline to the 2 month patient, with no AE; Initial information regarding an unsolicited valid non-serious case was received from a physician (Reference number- 00535851) and transmitted to Sanofi on 25-Mar-2021. This case involves a 2-months-old male patient who received vaccine 0.5 mL dose of suspect HIB (PRP/T) VACCINE [ACT-HIB] (batch number: UJ405AAB and expiry date: 10-Aug-2021) which was given with sterile water instead of saline (product preparation error) on an unknown date for prophylactic vaccination. The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided. It was an actual medication error case due to (wrong solution used in drug reconstitution) (latency: same day). Caller would like to know if they need to re-dose At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-